Skip to content
zameds

Empagliflozin

Sold as Jardiance, Losugby, Aziempa, Tuerizin, Empagliflozin zydus, Stenit, Pemfeg, Inglyflo, Empagliflozin unicorn, Empagliflozin PD, Empamak, Empagliflozin ascend, Meglyzin, Ampoldo

S4
Loading the molecular structure
C23H27ClO7450.90 g/mol

(2S,3R,4R,5S,6R)-2-[4-Chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol

Drag to rotate. Structure from PubChem CID 11949646.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
11
Registrations
27
Schedule source
Consolidated Schedules 06 July 2026

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Ingelheim Pharmaceuticals (Pty) Ltd û FerndaleJardiance10 mg, 25 mg480411, 481380S4None
Ruby Pharmaceuticals (Pty) LtdLosugby10 mg, 25 mg540649, 540650S4None
Austell Pharmaceuticals (Pty) LtdAziempa10mg, 25mg540651.649, 540652.65S4None
Zydus Healthcare (Pty) LtdTuerizin, Empagliflozin zydus10, 25550628, 550629, 550630.628, 550631.629S4None
Lebasi Pharmaceuticals (Pty) LtdStenit, Pemfeg10, 25560281, 560282.280, 560283.281S4None
Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr. Reddy’s Laboratories (Pty) Ltd.Inglyflo10, 25560284, 560285S4PIPIL
Unicorn Pharmaceuticals (Pty) LtdEmpagliflozin unicorn10, 20560700, 560701S4None
Pharma Dynamics (Pty) LtdEmpagliflozin PD10 mg, 25 mg560973, 560974S4None
Macleods Pharmaceuticals SA (Pty) LtdEmpamak10, 25561147, 561148S4None
Ascend Laboratories (Pty) LtdEmpagliflozin ascend10 mg, 25 mg570256, 570257S4None
Hetero Drugs South Africa (Pty) LtdMeglyzin, Ampoldo10, 25590387, 590388, 590389.387, 590390.388S4None

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Jardiance 25 MG

EACH TABLET CONTAINS EMPAGLIFLOZIN 25,0 mg

25 mg48041148/21.2/0411RegisteredS4None
Jardiance 10 MG

EACH TABLET CONTAINS EMPAGLIFLOZIN 10,0 mg

10 mg48138048/21.2/1380RegisteredS4None
Losugby 10 MG

EACH TABLET CONTAINS: EMPAGLIFLOZIN 10,0 mg

10 mg54064954/21.2/0649RegisteredS4None
Losugby 25 MG

EACH TABLET CONTAINS: EMPAGLIFLOZIN 25,0 mg

25 mg54065054/21.2/0650RegisteredS4None
Aziempa 10mg

EACH TABLET CONTAINS: EMPAGLIFLOZIN 10,0 mg

10mg540651.64954/21.2/0651.649RegisteredS4None
Aziempa 25mg

EACH TABLET CONTAINS: EMPAGLIFLOZIN 25,0 mg

25mg540652.6554/21.2/0652.650RegisteredS4None
Tuerizin 10

EACH TABLAET CONTAINS EMPAGLIFLOZIN 10,0 mg

1055062855/21.2/0628RegistreredS4None
Tuerizin 25

EACH TABLET CONTAINS EMPAGLIFLOZIN 25,0 mg

2555062955/21.2/0629RegistreredS4None
Empagliflozin 10 zydus

EACH TABLET CONTAINS EMPAGLIFLOZIN 10,0 mg

10550630.62855/21.2/0630.628RegistreredS4None
Empagliflozin 25 zydus

EACH TABLET CONTAINS EMPAGLIFLOZIN 25,0 mg

25550631.62955/21.2/0631.629RegistreredS4None
Stenit 25

EACH TABLET CONTAINS EMPAGLIFLOZIN 25,0 mg

2556028156/21.2/0281RegisteredS4None
Pemfeg 10

EACH TABLET CONTAINS EMPAGLIFLOZIN 10,0 mg

10560282.28056/21.2/0282.280RegisteredS4None
Pemfeg 25

EACH TABLET CONTAINS EMPAGLIFLOZIN 25,0 mg

25560283.28156/21.2/0283.281RegisteredS4None
Inglyflo 10

EACH TABLET CONTAINS EMPAGLIFLOZIN 10,0 mg

10Film-coated tablets56028456/21.2/0284Approved 17 February 2026RegisteredS4PIPIL
Inglyflo 25

EACH TABLET CONTAINS EMPAGLIFLOZIN 25,0 mg

25Film-coated tablets56028556/21.2/0285Approved 17 February 2026RegisteredS4PIPIL
Empagliflozin 10 unicorn

EACH TABLET CONTAINS EMPAGLIFLOZIN 10,0 mg

1056070056/21.2/0700RegisteredS4None
Empagliflozin 20 unicorn

EACH TABLET CONTAINS EMPAGLIFLOZIN 20,0 mg

2056070156/21.2/0701RegisteredS4None
Empagliflozin 10 MG PD

Each Tablet contains: Empagliflozin 10,0 mg

10 mg56097356/21.2/0973RegisteredS4None
Empagliflozin 25 MG PD

Each Tablet contains:Emagliflozin 25,0 mg

25 mg56097456/21.2/0974RegisteredS4None
Empamak 10

EACH TABLET CONTAINS EMPAGLIFLOZIN 10,0 mg

1056114756/21.2/1147RegisteredS4None
Empamak 25

EACH TABLET CONTAINS: EMPAGLIFLOZIN 10,0 mg

2556114856/21.2/1148RegisteredS4None
Empagliflozin 10 MG ascend

EACH TABLET CONTAINS: EMPAGLIFLOZIN 10,0 mg

10 mg57025657/21.2/0256RegisteredS4None
Empagliflozin 25 MG ascend

EACH TABLET CONTAINS: EMPAGLIFLOZIN 25,0 mg

25 mg57025757/21.2/0257RegisteredS4None
Meglyzin 10

EACH TABLET CONTAINS: EMPAGLIFLOZIN 10,0 mg

1059038759/21.2/0387RegisteredS4None
Meglyzin 25

EACH TABLET CONTAINS: EMPAGLIFLOZIN 25,0 mg

2559038859/21.2/0388RegisteredS4None
Ampoldo 10

EACH TABLET CONTAINS: EMPAGLIFLOZIN 10,0 mg

10590389.38759/21.2/0389.387RegisteredS4None
Ampoldo 25

EACH TABLET CONTAINS: EMPAGLIFLOZIN 25,0 mg

25590390.38859/21.2/0390.388RegisteredS4None

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Empagliflozin

  • S4: Empagliflozin

    Consolidated Schedules 06 July 2026, line 6176

Pharmacological class: Oral hypoglycaemics. (class 21.2)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Inglyflo 10, Dr Reddyæs Laboratories (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles